In the burgeoning Canadian cannabis industry, the opportunities – and risks – are immense. Industry participants need sophisticated strategies to prevail in a competitive and rapidly evolving market. Drawing on our cross-disciplinary experience, we design forward-thinking solutions that drive long-term success.

From the game-changing investment by Constellation Brands in Canopy Growth to the entry of Canadian tier 1 and global investment banks into this space, our team has been at the forefront of the industry’s recent significant and groundbreaking developments. Our understanding of the cannabis space – combined with our market-leading expertise in M&A, capital markets, competition, finance, tax and restructuring – allows us to advise incisively and commercially on the full range of cannabis business matters.

That’s why key players in the sector – including early-stage startups, licensed producers, investment banks, commercial lenders, private equity firms, retailers and pharmaceutical companies – trust our team to help them successfully navigate this dynamic industry.

Our experience and reach extends to all aspects of the cannabis business, both domestically and internationally. Whether you’re a startup requiring guidance on structuring and regulatory matters, an established producer seeking growth opportunities and commercial partnerships, or a venture capital firm looking to strategically invest in the space, we work with you to achieve your business goals.

Representative Work

Alimentation Couche-Tard Inc., 2019

Acted for Alimentation Couche-Tard Inc. (ACT) in its strategic investment in Fire & Flower Holdings Corp., a leading independent cannabis retailer based in Edmonton, Alberta, to (i) purchase $25,989,985.42 principal amount of 8% convertible unsecured debentures and (ii) be issued three series of share purchase warrants, which, if exercised in full, would subsequently increase ACT's ownership interest to 50.1% on a fully diluted basis.

Redwood Holdings, LLC, 2019

Acted for Redwood Holdings, LLC, in its US$300-million sale of U.S.-based Lord Jones, a luxury brand CBD business, to Cronos Group Inc., a Canadian publicly traded licensed cannabis producer.